|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2017. CA Cancer J Clin. 67:7–30. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kujawa KA and Lisowska KM: Ovarian
cancer-from biology to clinic. Postepy Hig Med Dosw (Online).
69:1275–1290. 2015.In Polish. View Article : Google Scholar
|
|
3
|
Ju X, Yu H, Liang D, Jiang T, Liu Y, Chen
L, Dong Q and Liu X: LDR reverses DDP resistance in ovarian cancer
cells by affecting ERCC-1, Bcl-2, Survivin and Caspase-3
expressions. Biomed Pharmacother. 102:549–554. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Liu J and Matulonis UA: New strategies in
ovarian cancer: Translating the molecular complexity of ovarian
cancer into treatment advances. Clin Cancer Res. 20:5150–5156.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hirata E and Sahai E: Tumor
microenvironment and differential responses to therapy. Cold Spring
Harb Perspect Med. 7:a0267812017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Quail DF and Joyce JA: Microenvironmental
regulation of tumor progression and metastasis. Nat Med.
19:1423–1437. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Aras S and Zaidi MR: TAMeless traitors:
Macrophages in cancer progression and metastasis. Br J Cancer.
117:1583–1591. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Orihuela R, McPherson CA and Harry GJ:
Microglial M1/M2 polarization and metabolic states. Br J Pharmacol.
173:649–665. 2016. View Article : Google Scholar :
|
|
9
|
Vinogradov S, Warren G and Wei X:
Macrophages associated with tumors as potential targets and
therapeutic intermediates. Nanomedicine (Lond). 9:695–707. 2014.
View Article : Google Scholar
|
|
10
|
Atri C, Guerfali FZ and Laouini D: Role of
human macrophage polarization in inflammation during infectious
diseases. Int J Mol Sci. 19:E18012018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Van Ginderachter JA, Movahedi K,
Hassanzadeh Ghassabeh G, Meerschaut S, Beschin A, Raes G and De
Baetselier P: Classical and alternative activation of mononuclear
phagocytes: Picking the best of both worlds for tumor promotion.
Immunobiology. 211:487–501. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bingle L, Brown NJ and Lewis CE: The role
of tumour-associated macrophages in tumour progression:
Implications for new anticancer therapies. J Pathol. 196:254–265.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lewis CE and Pollard JW: Distinct role of
macrophages in different tumor microenvironments. Cancer Res.
66:605–612. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Pollard JW: Tumour-educated macrophages
promote tumour progression and metastasis. Nat Rev Cancer. 4:71–78.
2004. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Feng R, Morine Y, Ikemoto T, Imura S,
Iwahashi S, Saito Y and Shimada M: Nrf2 activation drive
macrophages polarization and cancer cell epithelial-mesenchymal
transition during interaction. Cell Commun Signal. 16:542018.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang Z, Gerstein M and Snyder M: RNA-Seq:
A revolutionary tool for transcriptomics. Nat Rev Genet. 10:57–63.
2009. View
Article : Google Scholar
|
|
17
|
Lehtonen A, Ahlfors H, Veckman V,
Miettinen M, Lahesmaa R and Julkunen I: Gene expression profiling
during differentiation of human monocytes to macrophages or
dendritic cells. J Leukoc Biol. 82:710–720. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Li X, Wang W and Chen J: Recent progress
in mass spectrometry proteomics for biomedical research. Sci China
Life Sci. 60:1093–1113. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kaltashov IA, Pawlowski JW, Yang W,
Muneeruddin K, Yao H, Bobst CE and Lipatnikov AN: LC/MS at the
whole protein level: Studies of biomolecular structure and
interactions using native LC/MS and cross-path reactive
chromatography (XP-RC) MS. Methods. 144:14–26. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhong L, Zhou J, Chen X, Lou Y, Liu D, Zou
X, Yang B, Yin Y and Pan Y: Quantitative proteomics study of the
neuroprotec-tive effects of B12 on hydrogen peroxide-induced
apoptosis in SH-SY5Y cells. Sci Rep. 6:226352016. View Article : Google Scholar
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
22
|
Zeng C, Wang W, Yu X, Yang L, Chen S and
Li Y: Pathways related to PMA-differentiated THP1 human monocytic
leukemia cells revealed by RNA-Seq. Sci China Life Sci.
58:1282–1287. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Genin M, Clement F, Fattaccioli A, Raes M
and Michiels C: M1 and M2 macrophages derived from THP-1 cells
differentially modulate the response of cancer cells to etoposide.
BMC Cancer. 15:5772015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Tan Y, Feng Q, Sun X, Xue M, Jiang N and
Deng X: Effects of methylseleninic acid on cisplatin-resistant
ovarian cancer cells (SKOV3/DDP) and the mechanisms. Zhong Nan Da
Xue Xue Bao Yi Xue Ban. 41:1305–1311. 2016.In Chinese; Abstract
available in Chinese from the publisher.
|
|
25
|
Zheng P, Luo Q, Wang W, Li J, Wang T, Wang
P, Chen L, Zhang P, Chen H, Liu Y, et al: Tumor-associated
macrophages-derived exosomes promote the migration of gastric
cancer cells by transfer of functional Apolipoprotein E. Cell Death
Dis. 9:4342018. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Azimi A, Tuominen R, Costa Svedman F,
Caramuta S, Pernemalm M, Frostvik Stolt M, Kanter L, Kharaziha P,
Lehtiö J, Hertzman Johansson C, et al: Silencing FLI or targeting
CD13/ANPEP lead to dephosphorylation of EPHA2, a mediator of BRAF
inhibitor resistance, and induce growth arrest or apop-tosis in
melanoma cells. Cell Death Dis. 8:e30292017. View Article : Google Scholar
|
|
27
|
Salhia B, Kiefer J, Ross JT, Metapally R,
Martinez RA, Johnson KN, DiPerna DM, Paquette KM, Jung S, Nasser S,
et al: Integrated genomic and epigenomic analysis of breast cancer
brain metastasis. PLoS One. 9:e854482014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
De I, Steffen MD, Clark PA, Patros CJ,
Sokn E, Bishop SM, Litscher S, Maklakova VI, Kuo JS, Rodriguez FJ
and Collier LS: CSF1 Overexpression promotes high-grade glioma
formation without impacting the polarization status of
glioma-associated microglia and macrophages. Cancer Res.
76:2552–2560. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Piao J, You K, Guo Y, Zhang Y, Li Z and
Geng L: Substrate stiffness affects epithelial-mesenchymal
transition of cervical cancer cells through miR-106b and its target
protein DAB2. Int J Oncol. 50:2033–2042. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhu J, Zeng Y, Li W, Qin H, Lei Z, Shen D,
Gu D, Huang JA and Liu Z: CD73/NT5E is a target of miR-30a-5p and
plays an important role in the pathogenesis of non-small cell lung
cancer. Mol Cancer. 16:342017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yokoi A, Yoshioka Y, Yamamoto Y, Ishikawa
M, Ikeda SI, Kato T, Kiyono T, Takeshita F, Kajiyama H, Kikkawa F
and Ochiya T: Malignant extracellular vesicles carrying MMP1 mRNA
facilitate peritoneal dissemination in ovarian cancer. Nat Commun.
8:144702017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lin XL, He XL, Zeng JF, Zhang H, Zhao Y,
Tan JK and Wang Z: FGF21 increases cholesterol efflux by
upregulating ABCA1 through the ERK1/2-PPARγ-LXRα pathway in THP1
macrophage-derived foam cells. DNA Cell Biol. 33:514–521. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Goswami KK, Ghosh T, Ghosh S, Sarkar M,
Bose A and Baral R: Tumor promoting role of anti-tumor macrophages
in tumor microenvironment. Cell Immunol. 316:1–10. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Niu J and Li Z: The roles of integrin αvβ6
in cancer. Cancer Lett. 403:128–137. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhang T, Shao B and Liu GA: Rosuvastatin
promotes the differentiation of peripheral blood monocytes into M2
macrophages in patients with atherosclerosis by activating PPAR-γ.
Eur Rev Med Pharmacol Sci. 21:4464–4471. 2017.PubMed/NCBI
|
|
36
|
Noy R and Pollard JW: Tumor-associated
macrophages: From mechanisms to therapy. Immunity. 41:49–61. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Yu Z, Ye S, Hu G, Lv M, Tu Z, Zhou K and
Li Q: The RAF-MEK-ERK pathway: Targeting ERK to overcome obstacles
to effective cancer therapy. Future Med Chem. 7:269–289. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Kang H, Zhang J, Wang B, Liu M, Zhao J,
Yang M and Li Y: Puerarin inhibits M2 polarization and metastasis
of tumor-associated macrophages from NSCLC xenograft model via
inactivating MEK/ERK 1/2 pathway. Int J Oncol. 50:545–554. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Chanmee T, Ontong P, Konno K and Itano N:
Tumor-associated macrophages as major players in the tumor
microenvironment. Cancers (Basel). 6:1670–1690. 2014. View Article : Google Scholar
|
